Quan Anh Vu

Keine laufenden Positionen mehr

Vermögen: 287 066 $ am 31.05.2024

52 Jahre

Health Technology

Consumer Services

Finance

Ehemalige bekannte Positionen von Quan Anh Vu

Unternehmen	Position	Beginn	Ende
OCUGEN, INC.	Comptroller/Controller/Auditor	10.03.2023	14.08.2023
	Finanzdirektor/CFO	06.03.2023	14.08.2023
	Corporate Officer/Principal	01.02.2023	06.03.2023
180 LIFE SCIENCES CORP.	Geschäftsführer	29.10.2021	18.01.2023
Solganick & Co., Inc.	Corporate Officer/Principal	01.09.2019	01.10.2021
Baleena Bioscience, Inc.	Corporate Officer/Principal	01.04.2021	01.10.2021
OPIANT PHARMACEUTICALS, INC.	Corporate Officer/Principal	01.09.2016	01.08.2019

University of California, Los Angeles

Undergraduate Degree

International

Vereinigte Staaten	5
	2

Operativ

Corporate Officer/Principal	4
Undergraduate Degree	1
Chief Operating Officer	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
180 LIFE SCIENCES CORP.	Health Technology

Private Unternehmen	4
Solganick & Co., Inc.	Finance
Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA.	Health Technology
Baleena Bioscience, Inc.
Ocugen, Inc.